A. Van de Water

An improved method to correct the QT interval of the electrocardiogram for changes in heart rate

A. Van de Water, Jef Verheyen, R. Xhonneux et al. · Journal of Pharmacological Methods · 1989 · 318 citations

Heart Rate, Heart Failure, Improved Method +8

Pharmacological and Hemodynamic Profile of Nebivolol,* a Chemically Novel, Potent, and Selective β1-Adrenergic Antagonist

A. Van de Water, Wim Janssens, J. Van Neuten et al. · Journal of Cardiovascular Pharmacology · 1988 · 199 citations

Hypertension, Heart Failure, Cardiovascular Pharmacology +21

R 68 070: Thromboxane A2 Synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule - II. Pharmacological Effects In Vivo and Ex Vivo

Fred De Clerck, Johan Beetens, A. Van de Water et al. · Thrombosis and Haemostasis · 1989 · 88 citations

Cardioprotective effects of lidoflazine during 1-hour normothermic global ischemia.

Willem Flameng, Wim Daenen, F. Thoné et al. · Circulation · 1981 · 79 citations · Full text

Cardiovascular Toxicity, Heart Failure, Cardiogenic Shock +11

In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation

Hua Rong Lu, Eddy Vlaminckx, A. Van de Water et al. · European Journal of Pharmacology · 2006 · 62 citations

Risk Assessment, Antimicrobial Susceptibility, Antibiotics +11